Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -10.700% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CCc1ccccc1N(CC(=O)N1CCCCC1)S(=O)(=O)c1ccccc1
b CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(S(=O)(=O)c3cccc(F)c3)CC2)c1
c N=C1c2ccccc2CN1NC(=O)c1ccccc1
d Cc1ccc(C)c(S(=O)(=O)N2CCCC2CNC(=O)C(=O)NC2CCCC2)c1
Answer: b. CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(S(=O)(=O)c3cccc(F)c3)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(S(=O)(=O)c3cccc(F)c3)CC2)c1
CN(C)S(=O)(=O)c1ccc(N2CCCC2)c(C(=O)N2CCN(S(=O)(=O)c3cccc(F)c3)CC2)c1
3-[4-(3-fluorophenyl)sulfonylpiperazine-1-carbonyl]-N,N-dimethyl-4-pyrrolidin-1-ylbenzenesulfonamide